Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients
2014 · Genetics in Medicine · 335 citations
https://doi.org/10.1038/gim.2014.40
J
Jill S. Dolinsky
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
111
Papers
4.2K
Citations
27
h-index
38
i10-index
Jill S. Dolinsky is an academic researcher from Ambry Genetics (United States). The author has contributed to research in topics: BRCA gene mutations in cancer & Cancer Genomics and Diagnostics & Genetic factors in colorectal cancer. The author has an h-index of 27, co-authored 95 publications.
ORCID: 0000-0002-3854-9539Papers by this author
worksA clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients
2019 · Genetics in Medicine · 212 citations
https://doi.org/10.1038/s41436-019-0633-8
Diagnosing hereditary cancer predisposition in men with prostate cancer
2020 · Genetics in Medicine · 45 citations
https://doi.org/10.1038/s41436-020-0830-5
Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohort
2019 · Genetics in Medicine · 39 citations
https://doi.org/10.1038/s41436-019-0729-1
Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer
2020 · JNCI Journal of the National Cancer Institute · 36 citations
https://doi.org/10.1093/jnci/djaa167
Suggested application of HER2+ breast tumor phenotype for germline <i>TP53</i> variant classification within ACMG/AMP guidelines
2020 · Human Mutation · 22 citations
https://doi.org/10.1002/humu.24060
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat